SCHEMBL8434637

SCHEMBL8434637

CC(C)c1ccccc1OC(=O)CC(=O)Oc1ccccc1C(C)C

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.52
LMNA P02545 3/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 2/20 0.45
LPAR1 Q92633 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
NLRP3 Q96P20 1/20 0.44
KCNK3 O14649 1/20 0.44
KCNK9 Q9NPC2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43475 0.87 ELANE (0.49) CES2LMNAKMT2ACYP1A2TSHR
Butane SCHEMBL1044282 0.87 CES2 (0.46) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL5302718 0.85 CES2 (0.47) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL720572 0.84 KDM4E (0.55) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL991362 0.84 TSHR (0.50) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL11425288 0.84 KMT2A (0.50) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL9979219 0.82 TSHR (0.49) CES2LMNAKMT2ACYP1A2TSHR
SCHEMBL6398525 0.82 TSHR (0.49) CES2LMNAKMT2ACYP1A2TSHR
Hydrogen Peroxide SCHEMBL8008634 0.82 KDM4E (0.58) CES2LMNAKMT2ACYP1A2TSHR
Isoprocarb SCHEMBL64155 0.81 ALDH1A1 (0.65) CES2KMT2ACYP1A2TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed